Back
Skye Bioscience, Inc. 10K Form
Sell
18
SKYE
Skye Bioscience, Inc.
Last Price:
$1.19
Seasonality Move:
-20.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SKYE News And Ratings
See the #1 stock for the next 7 days that we like better than SKYE
SKYE Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-13.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.06 |
| Price / Book: | 1.18 |
Profitability
| EPS (TTM): | -1.28980 |
|---|---|
| Net Income (TTM): | $-51.2M |
| Gross Margin: | $-298.6K |
| Return on Equity: | -91.57% |
| Return on Assets: | -81.95% |
Skye Bioscience, Inc. Earnings Forecast
Key Skye Bioscience, Inc. Financial Ratios
-
Per Share Earnings over the last 13 years have been positive in 7 years.
Skye Bioscience, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | SKYE |
| Website: | skyebioscience.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 4.77 |
| Quick Ratio: | 4.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SKYE Technical Analysis vs Fundamental Analysis
Sell
18
Skye Bioscience, Inc. (SKYE)
is a Sell
Is Skye Bioscience, Inc. a Buy or a Sell?
-
Skye Bioscience, Inc. stock is rated a SellThe current Skye Bioscience, Inc. [SKYE] share price is $1.21. The Score for SKYE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.